The DOI matches its OpenAlex record; 91 of the 91 references it cites were found in a registry or an index.
Combined oral contraceptive pills for treatment of acne
Open accessAbstract
BACKGROUND: Acne is a common skin disorder among women. Although no uniform approach to the management of acne exists, combination oral contraceptives (COCs), which contain an estrogen and a progestin, often are prescribed for women. OBJECTIVES: To determine the effectiveness of combined oral contraceptives (COCs) for the treatment of facial acne compared to placebo or other active therapies. SEARCH METHODS: In January 2012, we searched for randomized controlled trials of COCs and acne in the computerized databases of the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE, EMBASE, POPLINE, and LILACS. We also searched for clinical trials in ClinicalTrials.gov and the International Clinical Trials Registry Platform (ICTRP) (Aug 2011). For the initial review, we wrote to researchers to seek any unpublished or published trials that we might have missed. SELECTION CRITERIA: We considered randomized controlled trials reported in any language that compared the effectiveness of a COC containing an estrogen and a progestin to placebo or another active therapy for acne in women. DATA COLLECTION AND ANALYSIS: We extracted data on facial lesion counts, both total and specific (i.e., open or closed comedones, papules, pustules and nodules); acne severity grades; global assessments by the clinician or the participant, and discontinuation due to adverse events. Data were entered and analyzed in RevMan. For continuous data, we calculated the mean difference (MD) and 95% confidence interval (CI). For dichotomous data, we calculated the Peto odds ratio (OR) and 95% CI. MAIN RESULTS: The review includes 31 trials with 12,579 participants. Of 24 comparisons made, 6 compared a COC to placebo, 17 different COCs, and 1 compared a COC to an antibiotic. Of nine placebo-controlled trials with data for analysis, all showed COCs reduced acne lesion counts, severity grades and self-assessed acne compared to placebo. A levonorgestrel-COC group had fewer total lesion counts (MD -9.98; 95% CI -16.51 to -3.45), inflammatory and non-inflammatory lesion counts, and were more likely to have a clinician assessment of clear or almost clear lesions and participant self-assessment of improved acne lesions. A norethindrone acetate COC had better results for clinician global assessment of no acne to mild acne (OR 1.86; 95% CI 1.32 to 2.62). In two combined trials, a norgestimate COC showed reduced total lesion counts (MD-9.32; 95% CI -14.19 to -4.45), reduced inflammatory lesion and comedones counts, and more with clinician assessment of improved acne. For two combined trials of a drospirenone COC, the investigators' assessment of clear or almost clear skin favored the drospirenone group (OR 3.02; 95% CI 1.99 to 4.59). In one trial, the drospirenone-COC group showed greater (more positive) percent changes for total lesion count (MD 29.08; 95% CI 3.13 to 55.03), inflammatory and non-inflammatory lesion counts, and papule and closed comedone counts. A dienogest-COC group had greater percentage decreases in total lesion count (MD -15.30; 95% CI -19.98 to -10.62) and inflammatory lesion count, and more women assessed with overall improvement of facial acne. A CMA-COC group had more 'responders,' those with 50% or greater decrease in facial papules and pustules (OR 2.31; 95% CI 1.50 to 3.55)Differences in the comparative effectiveness of COCs containing varying progestin types and dosages were less clear, and data were limited for any particular comparison. COCs that contained chlormadinone acetate or cyproterone acetate improved acne better than levonorgestrel. A COC with cyproterone acetate showed better acne outcomes than one with desogestrel, but the studies produced conflicting results. Likewise, levonorgestrel showed a slight improvement over desogestrel in acne outcomes, but results were not consistent. A drospirenone COC appeared to be more effective than norgestimate or nomegestrol acetate plus 17β-estradiol but less effective than cyproterone acetate. AUTHORS' CONCLUSIONS: This update yielded six new trials but no change in conclusions. The six COCs evaluated in placebo-controlled trials are effective in reducing inflammatory and non-inflammatory facial acne lesions. Few important and consistent differences were found between COC types in their effectiveness for treating acne. How COCs compare to alternative acne treatments is unknown since only one trial addressed this issue. The use of standardized methods for assessing acne severity would help in synthesizing results across trials as well as aid in interpretation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Moher, D., Schulz, K. F., & Altman, D. G. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04337-3 · Cited by 5,373
Pharmaceutical industry sponsorship and research outcome and quality: systematic review
Lexchin, J., Bero, L. A., Djulbegovic, B., & Clark, O. (2003) · BMJ · doi:10.1136/bmj.326.7400.1167 · Cited by 2,147
Blinding in randomised trials: hiding who got what
Schulz, K. F., & Grimes, D. A. (2002) · The Lancet · doi:10.1016/s0140-6736(02)07816-9 · Cited by 952
Self-citationAllocation concealment in randomised trials: defending against deciphering
Schulz, K. F., & Grimes, D. A. (2002) · The Lancet · doi:10.1016/s0140-6736(02)07750-4 · Cited by 923
Self-citationRobinson, K. A., & Dickersin, K. (2002) · International Journal of Epidemiology · doi:10.1093/ije/31.1.150 · Cited by 833
Prevalence of facial acne in adults☆, ☆☆, ★
GOULDEN, V, STABLES, G., & CUNLIFFE, W. (1999) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(99)70300-2 · Cited by 423
Toyoda, M., & Morohashi, M. (2001) · Medical Electron Microscopy · doi:10.1007/s007950100002 · Cited by 383
Oral contraceptives and venous thromboembolism: a five-year national case-control study☆
Lidegaard, Ø., Edström, B., & Kreiner, S. (2002) · Contraception · doi:10.1016/s0010-7824(01)00307-9 · Cited by 334
An epidemiological study of acne in female adults: results of a survey conducted in France
Poli, F., Dreno, B., & Verschoore, M. (2001) · Journal of the European Academy of Dermatology and Venereology · doi:10.1046/j.1468-3083.2001.00357.x · Cited by 284
Leyden, J. J. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704173361607 · Cited by 252
REDMOND, G., OLSON, W., LIPPMAN, J., KAFRISSEN, M., JONES, T., & JORIZZO, J. (1997) · Obstetrics & Gynecology · doi:10.1016/s0029-7844(97)00059-8 · Cited by 221
Effectiveness of norgestimate and ethinyl estradiol in treating moderate acne vulgaris
Lucky, A. W., Henderson, T. A., Olson, W. H., Robischb, D. M., Lebwohl, M., & Swinyer, L. J. (1997) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(97)70112-9 · Cited by 201
Vexiau, P., Chaspoux, C., Boudou, P., Fiet, J., Jouanique, C., Hardy, N., & Reygagne, P. (2002) · British Journal of Dermatology · doi:10.1046/j.1365-2133.2002.04798.x · Cited by 197
Shorter pill-free interval in combined oral contraceptives decreases follicular development
Spona, J., Elstein, M., Feichtinger, W., Sullivan, H., Lüdicke, F., Müller, U., & Düsterberg, B. (1996) · Contraception · doi:10.1016/0010-7824(96)00137-0 · Cited by 187
van Vloten, W. A., van Haselen, C. W., van Zuuren, E. J., Gerlinger, C., & Heithecker, R. (2002) · PubMed · Cited by 173
Evaluation of a Unique Oral Contraceptive in the Treatment of Premenstrual Dysphoric Disorder
Freeman, E. W., Kroll, R., Rapkin, A., Pearlstein, T., Brown, C., Parsey, K., Zhang, P., Patel, H., & Foegh, M. (2001) · Journal of Women's Health & Gender-Based Medicine · doi:10.1089/15246090152543148 · Cited by 163
Risk of venous thromboembolism with cyproterone or levonorgestrel contraceptives
Vasilakis-Scaramozza, C., & Jick, H. (2001) · The Lancet · doi:10.1016/s0140-6736(01)06522-9 · Cited by 160
Clinical reviewAcne vulgarisCommentary: A UK primary care perspective on treating acne
WEBSTER, G. F., Poyner, T., & Cunliffe, B. (2002) · BMJ · doi:10.1136/bmj.325.7362.475 · Cited by 159
Huber, J., Foidart, J., Wuttke, W., Merki‐Feld, G. S., The, H. S., Gerlinger, C., Schellschrmdt, I., & Heithecker, R. (2000) · The European Journal of Contraception & Reproductive Health Care · doi:10.1080/13625180008500375 · Cited by 147
Eady, E. A., Farmery, M. R., Ross, J. I., Cove, J. H., & Cunliffe, W. J. (1994) · British Journal of Dermatology · doi:10.1111/j.1365-2133.1994.tb08519.x · Cited by 137
George, R., Clarke, S. B., & Thiboutot, D. M. (2008) · Seminars in Cutaneous Medicine and Surgery · doi:10.1016/j.sder.2008.06.002 · Cited by 131
Coney, P., Washenik, K., Langley, R. G. B., DiGiovanna, J. J., & Harrison, D. D. (2001) · Contraception · doi:10.1016/s0010-7824(01)00208-6 · Cited by 123
Effect of low-dose oral contraceptives on androgenic markers and acne
Thorneycroft, I. H., Stanczyk, F. Z., Bradshaw, K. D., Ballagh, S. A., Nichols, M. D. N., & Weber, M. E. (1999) · Contraception · doi:10.1016/s0010-7824(99)00093-1 · Cited by 119
New progestogens in oral contraception
Fotherby, K., & Caldwell, A. D. S. (1994) · Contraception · doi:10.1016/0010-7824(94)90106-6 · Cited by 113
Thorneycroft, L. H., Gollnick, H., & Schellschmidt, I. (2004) · PubMed · Cited by 103
New Treatments and Therapeutic Strategies for Acne
Thiboutot, D. M. (2000) · Archives of Family Medicine · doi:10.1001/archfami.9.2.179 · Cited by 103
Mansour, D., Verhoeven, C., Sommer, W., Weisberg, E., Taneepanichskul, S., Melis, G. B., Poromaa, I. S., & Korver, T. (2011) · The European Journal of Contraception & Reproductive Health Care · doi:10.3109/13625187.2011.614029 · Cited by 102
Oral contraceptives and fatal pulmonary embolism
Parkin, L., Skegg, D. C. G., Wilson, M., Herbison, P., & Paul, C. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02382-5 · Cited by 100
Palatsi, R., Hirvensalo, E., Liukko, P., Malmiharju, T., Mattila, L., Riihiluoma, P., & Ylöstalo, P. (1984) · Acta Dermato-Venereologica · doi:10.2340/0001555564517523 · Cited by 98
Koltun, W. D., Lucky, A. W., Thiboutot, D. M., Niknian, M., Sampson-Landers, C., Korner, P., & Marr, J. (2008) · Contraception · doi:10.1016/j.contraception.2007.11.003 · Cited by 97
Thiboutot, D., Archer, D. F., Lemay, A., Washenik, K., Roberts, J., & Harrison, D. D. (2001) · Fertility and Sterility · doi:10.1016/s0015-0282(01)01938-0 · Cited by 96
Anti-androgen treatment in women with acne: a controlled trial
Miller, J., WOJNAROWSKA, F. T., Dowd, P. M., Ashton, R. E., O’Brien, T., Griffiths, W. A. D., & Jacobs, H. S. (1986) · British Journal of Dermatology · doi:10.1111/j.1365-2133.1986.tb04880.x · Cited by 90
Worret, I., Arp, W., Zahradnik, H. P., Andreas, J., & Binder, N. (2001) · Dermatology · doi:10.1159/000051701 · Cited by 88
Inhibition of skin 5α-reductase by oral contraceptive progestinsin vitro
Rabe, T., Kowald, A., Ortmann, J., & Rehberger-Schneider, S. (2000) · Gynecological Endocrinology · doi:10.3109/09513590009167685 · Cited by 84
Leyden, J., Shalita, A., Hordinsky, M., Swinyer, L., Stanczyk, F. Z., & Weber, M. E. (2002) · Journal of the American Academy of Dermatology · doi:10.1067/mjd.2002.122192 · Cited by 80
The interaction between acne vulgaris and the psyche.
Baldwin, H. E. (2002) · PubMed · Cited by 75
Jemec, G. B. E., Linneberg, A. R., Nielsen, N. H., FRØLUND, L., Madsen, F., & Jørgensen, T. (2002) · Dermatology · doi:10.1159/000057878 · Cited by 75
Kelly, S., Davies, E., Fearns, S., McKinnon, C., Carter, R., Gerlinger, C., & Smithers, A. (2010) · Clinical Drug Investigation · doi:10.2165/11535450-000000000-00000 · Cited by 73
Greenwood, R., Brummitt, L., Burke, B., & Cunliffe, W. J. (1985) · BMJ · doi:10.1136/bmj.291.6504.1231 · Cited by 73
Maloney, J. M., Dietze, P., Watson, D., Niknian, M., Lee-Rugh, S., Sampson-Landers, C., & Korner, P. (2008) · Obstetrics & Gynecology · doi:10.1097/aog.0b013e318187e1c5 · Cited by 68
Modelling the remission of individual acne lesions in vitro
Downie, M. M. T., Sanders, D. A., & Kealey, T. (2002) · British Journal of Dermatology · doi:10.1046/j.1365-2133.2002.04946.x · Cited by 68
Winkler, U. H., Ferguson, H., & Mulders, J. A. P. A. (2004) · Contraception · doi:10.1016/j.contraception.2003.12.017 · Cited by 67
Clinical evidence of the minimal androgenic activity of norgestimate.
Chapdelaine, A., Jl, D., & Derman, R. J. (1989) · PubMed · Cited by 65
Carlborg, L. (1986) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.3109/00016348609157049 · Cited by 63
Topical Cyproterone Acetate Treatment in Women With Acne: A Placebo-Controlled Trial
Gruber, D. M., Sator, M. O., Joura, E. A., Kokoschka, E., Heinze, G., & Huber, J. C. (1998) · Archives of Dermatology · doi:10.1001/archderm.134.4.459 · Cited by 59
Archer, D. F., Maheux, R., DelConte, A., & O’Brien, F. B. (1999) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(99)70362-5 · Cited by 57
Rosen, M. P., Breitkopf, D. M., & Nagamani, M. (2003) · American Journal of Obstetrics and Gynecology · doi:10.1067/mob.2003.294 · Cited by 56
Erkkola, R., Hirvonen, E., Luikku, J., Lumme, R., Männikkö, H., & Avdinlik, S. (1990) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.3109/00016349009021041 · Cited by 53
Mango, D., Ricci, S., Manna, P., Miggiano, G. A. D., & Serra, G. B. (1996) · Contraception · doi:10.1016/0010-7824(96)00005-4 · Cited by 53
Effects of sex steroids on skin 5 alpha-reductase activity in vitro.
Cassidenti, D. L., Paulson, R. J., Serafini, P., Stanczyk, F. Z., & Lobo, R. A. (1991) · PubMed · Cited by 51
The evaluation and management of acne: Economic considerations
Bergfeld, W. F. (1995) · Journal of the American Academy of Dermatology · doi:10.1016/0190-9622(95)90421-2 · Cited by 49
Palombo‐Kinne, E., Schellschmidt, I., Schumacher, U., & Gräser, T. (2008) · Contraception · doi:10.1016/j.contraception.2008.10.010 · Cited by 45
Plewig, G., Cunliffe, W. J., Binder, N., & Höschen, K. (2009) · Contraception · doi:10.1016/j.contraception.2009.02.016 · Cited by 44
Cremoncini, C., Vignati, E., & Libroia, A. (1976) · PubMed · Cited by 43
WEBSTER, G. F. (2002) · PubMed · Cited by 43
Effects on acne of two oral contraceptives containing desogestrel and cyproterone acetate.
Charoenvisal, C., Thaipisuttikul, Y., Pinjaroen, S., Krisanapan, O., Benjawang, W., Koster, A., & Doesburg, W. H. (1996) · PubMed · Cited by 41
Koltun, W. D., Maloney, J. M., Marr, J., & Kunz, M. (2011) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2010.12.027 · Cited by 39
Koetsawang, S., Charoenvisal, C., Banharnsupawat, L., Singhakovin, S., Kaewsuk, O., & Punnahitanont, S. (1995) · Contraception · doi:10.1016/0010-7824(95)00037-b · Cited by 37
Palli, M. A., Reyes-Habito, C. M., Lima, X. T. V., & Kimball, A. B. (2013) · PubMed · Cited by 34
Fugère, P., Percival-Smith, R. K. L., Lussier‐Cacan, S., Davignon, J., & Farquhar, D. (1990) · Contraception · doi:10.1016/0010-7824(90)90106-6 · Cited by 34
Vartiainen, M., de Gezelle, H., & Broekmeulen, C. J. H. (2001) · The European Journal of Contraception & Reproductive Health Care · doi:10.1080/ejc.6.1.46.53 · Cited by 34
THE DEVELOPMENT AND EVALUATION OF AN OVULATION INHIBITOR (DIANE®) CONTAINING AN ANTIANDROGEN
Lachnit-Fixson, U. (1979) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.3109/00016347909157227 · Cited by 34
Vermeulen, A., & Rubens, R. (1988) · Contraception · doi:10.1016/0010-7824(88)90083-2 · Cited by 34
Lucky, A. W., Koltun, W. D., Thiboutot, D. M., Niknian, M., Sampson-Landers, C., Korner, P., & Marr, J. (2008) · PubMed · Cited by 32
Maloney, J. M., Arbit, D. I., Flack, M., McLaughlin-Miley, C., Sevilla, C., & Derman, R. J. (2001) · Clinical Journal of Women s Health · doi:10.1053/cjwh.2001.25638 · Cited by 29
Carmina, E., Godwin, A., Stanczyk, F. Z., Lippman, J. S., & Løbo, R. A. (2002) · Journal of Endocrinological Investigation · doi:10.1007/bf03345509 · Cited by 29
AN OPEN STUDY OF TRIPHASIL AND DIANE 50 IN THE TREATMENT OF ACNE
Wishart, J. (1991) · Australasian Journal of Dermatology · doi:10.1111/j.1440-0960.1991.tb00683.x · Cited by 28
Dieben, T. O. M., Vromans, L., Theeuwes, A., & Bennink, H. J. T. C. (1994) · Contraception · doi:10.1016/0010-7824(94)90024-8 · Cited by 28
Palatsi, R., Reinilä, M., & Kivinen, S. (1986) · Acta Dermato Venereologica · doi:10.2340/0001555566225230 · Cited by 28
Wendler, J., Siegert, C., Schelhorn, P., Klinger, G., Gurr, S., Kaufmann, J., Aydınlık, S., & Braunschweig, T. (1995) · Contraception · doi:10.1016/0010-7824(96)87703-1 · Cited by 26
Gruber, D. M., Huber, J. C., Melis, G. B., Stagg, C., Parke, S., & Marr, J. (2006) · Treatments in Endocrinology · doi:10.2165/00024677-200605020-00005 · Cited by 26
Halbe, H. W., de Melo, N. R., Bahamondes, L. G., Petracco, Á., Lemgruber, M., de Andrade, R. P., da Cunha, D. C., Guazelli, C., & Baracat, E. C. (1998) · The European Journal of Contraception & Reproductive Health Care · doi:10.3109/13625189809051413 · Cited by 26
Effect of a desogestrel-containing oral contraceptive on the skin
Katz, H. I., Kempers, S. E., Akin, M., DUNLAP, F. E., Whiting, D., & Norbart, T. C. J. (2000) · The European Journal of Contraception & Reproductive Health Care · doi:10.1080/13625180008500411 · Cited by 25
Moradan, S., & Ziba, O. (2011) · Saudi Medical Journal · doi:10.15537/1658-3175.5206 · Cited by 24
Effects of Benzoyl Peroxide on Lipogenesis in Sebaceous Glands Using an Animal Model
Burkhart, C. G., Butcher, C., Burkhart, C. N., & Lehmann, P. F. (2000) · Journal of Cutaneous Medicine and Surgery · doi:10.1177/120347540000400305 · Cited by 23
The duration of response to norgestimate and ethinyl estradiol in the treatment of acne vulgaris.
Olson, W. H., Lippman, J. S., & Robisch, D. M. (1999) · PubMed · Cited by 20
Pharmacology of hormonal contraceptives and acne.
White, K. O., & Westhoff, C. L. (2008) · PubMed · Cited by 20
Differences in the use of combined oral contraceptives amongst women with and without acne
Seaman, H. E. (2003) · Human Reproduction · doi:10.1093/humrep/deg090 · Cited by 20
Efficacy of low-dose cyproterone acetate compared with minocycline in the treatment of acne vulgaris
Monk, B. E., ALMEYDA, J. A., Caldwell, I. W., GREEN, B., Pelta, D. E., LEONARD, J. N., du Vivier, A. W. P., JOHNSON, K., & Tolowinska, I. (1987) · Clinical and Experimental Dermatology · doi:10.1111/j.1365-2230.1987.tb02499.x · Cited by 19
Vegetti, W., Testa, G., Maggioni, P., Motta, T., Falsetti, L., & Crosignani, P. G. (2010) · Gynecologic and Obstetric Investigation · doi:10.1159/000292281 · Cited by 19
Volpe, A., Silferi, M., Mauri, A., Deiana, P., Angioni, S. L., Grasso, A., & Genazzani, A. R. (1994) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/0028-2243(94)90120-1 · Cited by 18
Maloney, J. M., Dietze, P., Watson, D. I., Niknian, M., Lee-Rugh, S., Sampson-Landers, C., & Korner, P. (2009) · PubMed · Cited by 17
Weber-Diehl, F., Lehnen, J., & Lachnit, U. (1993) · Contraception · doi:10.1016/0010-7824(93)90076-j · Cited by 15
Cycle control with oral contraceptives containing 20 μg of ethinyl estradiol
DelConte, A., Loffer, F., & Grubb, G. S. (1999) · Contraception · doi:10.1016/s0010-7824(99)00019-0 · Cited by 15
Hormonal contraceptives for acne management.
Rich, P. A. (2008) · PubMed · Cited by 13
Aydınlık, S., Lachnit-Fixson, U., & Lehnert, J. (1986) · PubMed · Cited by 13
Lachnit-Fixson, U., & Kaufmann, J. (1977) · PubMed · Cited by 12
Die ovarielle Suppression unter Diane 35/50®
Erdmann, D., Schindler, E.-M., & Schindler, A. E. (1994) · Geburtshilfe und Frauenheilkunde · doi:10.1055/s-2007-1022354 · Cited by 11
Grund, E., & Schmidt-Elmendorff, H. (1975) · PubMed · Cited by 10
A randomized double blind study of two oral contraceptives
Sanhueza, H., Sivin, I., Kumar, S., Kessler, M., Carrasco, A., & Yee, J. (1979) · Contraception · doi:10.1016/0010-7824(79)90042-8 · Cited by 8
Mehrl, J. (1988) · PubMed · Cited by 5
Cited by
Guidelines of care for the management of acne vulgaris
Zaenglein, A. L., Pathy, A. L., Schlosser, B. J., Alikhan, A., Baldwin, H. E., Berson, D. S., Bowe, W. P., Graber, E. M., Harper, J. C., Kang, S., et al. (2016) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2015.12.037 · Cited by 1,597
van Hylckama Vlieg, A., Helmerhorst, F. M., Vandenbroucke, J. P., Doggen, C. J. M., & Rosendaal, F. R. (2009) · BMJ · doi:10.1136/bmj.b2921 · Cited by 666
Guidelines of care for the management of acne vulgaris
Reynolds, R. V., Yeung, H., Cheng, C. E., Cook-Bolden, F., Desai, S. R., Druby, K. M., Freeman, E. E., Keri, J. E., Stein Gold, L. F., Tan, J. K. L., et al. (2024) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2023.12.017 · Cited by 518
TFOS DEWS II Sex, Gender, and Hormones Report
Sullivan, D. A., Rocha, E. M., Aragona, P., Clayton, J. A., Ding, J., Golebiowski, B., Hampel, U., McDermott, A. M., Schaumberg, D. A., Srinivasan, S., et al. (2017) · The Ocular Surface · doi:10.1016/j.jtos.2017.04.001 · Cited by 434
Thiboutot, D. M., Dréno, B., Abanmi, A., Alexis, A. F., Araviiskaia, E., Barona Cabal, M. I., Bettoli, V., Casintahan, F., Chow, S., da Costa, A., et al. (2018) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2017.09.078 · Cited by 418
Metadata
- Authors
- Arowojolu, A. O., Gallo, M. F., Lopez, L. M., & Grimes, D. A.
- Venue
- Cochrane Database of Systematic Reviews
- Publisher
- Elsevier BV
- Published
- 2012-07-06
- Issue
- 7
- Pages
- CD004425-CD004425
- ISSN
- 1361-6137 (ISSN-L)
- OpenAlex
- W2116297033
- Cited by
- 308
- References
- 91
- Type
- reference entry
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.